;
Home | Accelerate@Babraham | Accelerate@Babraham Experts | Andrew Sandham

Andrew Sandham

Chairman, PredictImmune Ltd

Andrew has more than 30 years’ experience in co-founding and building start-up businesses in the biotechnology sector in the UK and US. He has served in chairman, non-executive and executive roles with UK and US biotech start-up companies, including Cantab Pharmaceuticals, Hexagen, Signature Bioscience, Novacta, Ionix Pharmaceuticals, NeurAxon, Syntaxin, Synosia, Kymab, Bicycle Therapeutics, 14M Genomics and PredictImmune. He has also worked within venture capital firms Abingworth and Syncona and currently serves as a director of Plant Bioscience (PBL) and is deputy chairman of the Cambridge Enterprise Investment Committee.

Contact us

BABRAHAM RESEARCH
CAMPUS

(+44) 1223 496 000
info@babraham.co.uk

Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge
CB22 3AT, United Kingdom

Press Enquiries

Limewash
01223 813 557
info@limewash.co.uk

Subscribe to our mailing list

Please enter your first name
Please enter your surname
Please enter your email address
Submit
; ;